Older age, lack of vaccination and infection with variants other than Omicron associated with severity of COVID-19 and in-hospital mortality in Pakistan
暂无分享,去创建一个
U. Aamir | N. Nasir | A. Nasir | A. Kanji | S. Mahmood | Z. Hasan | Z. Mushtaq | S. Khan
[1] M. Santillana,et al. Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South Africa , 2022, The Lancet Microbe.
[2] N. Ghanchi,et al. SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma, Delta, and Omicron coincident with consecutive pandemic waves in Pakistan , 2022, medRxiv.
[3] Mufakhara Fatimah,et al. Safety and efficacy of Sinopharm vaccine (BBIBP-CorV) in elderly population of Faisalabad district of Pakistan , 2022, Postgraduate medical journal.
[4] S. Bhatt,et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study , 2022, The Lancet.
[5] A. Charlett,et al. Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection , 2022, The New England journal of medicine.
[6] Liyuan Liu,et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages , 2022, Nature.
[7] Xiao Chen,et al. Impact of vaccination on the COVID-19 pandemic in U.S. states , 2022, Scientific Reports.
[8] J. Bhiman,et al. Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa , 2021, medRxiv.
[9] Ezekiel J. Maier,et al. SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load , 2021, medRxiv.
[10] S. A. Haider,et al. Genomic surveillance reveals the detection of SARS‐CoV‐2 delta, beta, and gamma VOCs during the third wave in Pakistan , 2021, Journal of medical virology.
[11] S. A. Haider,et al. Tracking down B.1.351 SARS‐CoV‐2 variant in Pakistan through genomic surveillance , 2021, Journal of medical virology.
[12] M. A. Syed,et al. Changing SARS-CoV-2 variants in Karachi, Pakistan from alpha to delta through COVID-19 waves three and four , 2021 .
[13] B. Souza,et al. SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021 , 2021, International Journal of Infectious Diseases.
[14] N. Nasir,et al. Clinical characteristics and outcomes of COVID-19: Experience at a major tertiary care center in Pakistan. , 2021, Journal of infection in developing countries.
[15] Samir N. Patel,et al. COVID-19 Hospitalizations, ICU Admissions and Deaths Associated with the New Variants of Concern , 2021 .
[16] L. Danon,et al. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study , 2021, BMJ.
[17] J. Nkengasong,et al. The puzzle of the COVID-19 pandemic in Africa , 2020, Science.
[18] M. Roser,et al. Coronavirus Pandemic (COVID-19) , 2020 .
[19] S. Carmichael,et al. Variants , 2018, The Works of Aphra Behn.
[20] Clinical Spectrum of SARS-CoV-2 Infection , 2022 .